NCT00397527已完成3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up of Dermacyd Wipes
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Adverse events and their association with the treatment.
研究概览
简要总结
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Wipes
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Integral skin in the tested region
排除标准
- •Pregnancy or breastfeeding women;
- •Use of antiinflammatory or immunosuppression drugs;
- •Topical medication use at the region to be treated;
- •Cutaneous disease or active gynaecological disease which may interfer in study results;
- •Personal history of allergic disease at the area to be treated;
- •Allergic or atopic history.
结局指标
主要结局
Adverse events and their association with the treatment.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - HygieneHygieneNCT00370162Sanofi30
已完成
4 期
Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)HygieneNCT00497783Sanofi30
已完成
4 期
Acceptability of Lactacyd FeminaHygieneNCT00712868Sanofi559
已完成
4 期
Dermacyd Infantile - Acceptability.HygieneNCT00881270Sanofi31
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerHygieneNCT00663273Sanofi30